VIB today introduces an upgrade to its toolbox for structural analysis of biological molecules, leading the way for drug development. These tools help to overcome critical obstacles that limit the resolution of cryo-electron microscopy (cryo-EM) reconstructions.
Each year, Clarivate publishes a ‘highly cited researchers’ list recognizing pioneers in their field. This list contains researchers who have demonstrated significant influence through the publication of multiple papers, highly cited by their peers, during the last decade (2009-2019). No less than 19 VIB researchers are part of this highly acclaimed group of influential scientists.
EMBO is an organization that unites leading researchers in the life sciences to promotes scientific excellence. Every year, new members are selected from among Europe’s top-scientists. This year, Jean-Christophe Marine (VIB-KU Leuven), Jan Steyaert (VIB-VUB), and Alain Goossens (VIB-UGent) join the other VIB EMBO members.
How the Nanobody expertise of Jan Steyaert's lab contributes to new discoveries. 2018 was a year full of highlights for Jan Steyaert (VIB-VUB Center for Structural Biology) and his research team, with two papers published in Cell and four in Nature. The trend continues in 2019, with two Nature publications, one Cell paper and a key technology licensing agreement already in the books.
The Center for Structural Biology (VIB-VUB), headed by Professors Jan Steyaert and Han Remaut officially opened the ‘international facility for Bio Electron Cryogenic Microscopy’ (BECM) at the VUB Campus in Brussels. The research center houses the a new kind cryo-electron microscope (cryo-EM), one of just three in the world. The microscope pushes the boundaries of research into active proteins for the development of medicines and, thanks to its unique properties, will be operating on a 24/7 basis.
Wim Versées, staff scientists at the VIB-VUB Center for Structural Biology, received a Michael J. Fox Foundation grant. The foundation provides funding for translational and clinical research supporting Parkinson’s-related breakthroughs.
People in and around VIB are well aware of our adage: basic research as a starting point for tangible solutions that benefit society. But translating a paper or a technology into a groundbreaking new drug or agricultural application doesn’t happen overnight. The importance of the tech transfer process was recently illustrated by a study led by Nico Callewaert (VIB-UGent) and Jan Steyaert (VIB-VUB). The paper presents a technology platform for synthetic biology, and is a great example of how innovation and entrepreneurship go hand in hand.
Increasing the concentration of specific fats in the brain could suppress epileptic seizures. This is evident from ground-breaking research carried out by the research groups of Professor Patrik Verstreken (VIB-KU Leuven) and Professor Wim Versées (VIB-Vrije Universiteit Brussel). The results of their close collaboration have been published in the leading trade journal Nature Structural & Molecular Biology.